Darbelife 40mcg Pfs Injection
By Darbelife
Rx
1 Injection in a Vial

Composition
Darbepoetin alfa(40mcg)

Manufacturer - Hetero Drugs Ltd
7-2-A2, Hetero Corporate, Industrial Estates, Sanath Nagar, Hyderabad – 500 018. Telangana, INDIA

Expires on or after
September, 2025

liver
When using Darbelife 40mcg Pfs Injection, it is essential to proceed with caution, especially if you have a history of liver disease. Patients with liver issues may require a dose adjustment when using Darbelife 40mcg Pfs Injection. It is crucial to consult your doctor for proper guidance on the use of this medication in such cases.

kidney
Darbelife 40mcg Pfs Injection is considered safe for patients with kidney disease. It is not necessary to adjust the dose of Darbelife 40mcg Pfs Injection for these patients.

alcohol
It is not known if it is safe to drink alcohol while using Darbelife 40mcg Pfs Injection. Consult your doctor for guidance.

driving
When using Darbelife 40mcg Pfs Injection, it is noted that it generally does not impact your driving ability.

pregnancy
Darbelife 40mcg Pfs Injection may not be safe to use during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will assess the benefits versus risks before prescribing. Consult your doctor for more information.

breastfeeding
Caution should be exercised if breastfeeding while using Darbelife 40mcg Pfs Injection due to possible harm to the baby through drug transmission in breastmilk.
Habit Forming | No |
Chemical Class | Amino Acids, Peptides, and Analogues |
Therapeutic Class | BLOOD RELATED |
Action Class | Erythropoiesis-stimulating agent (ESA) |
₹2755
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025